Hirotoshi Echizen - JoVE Visualize

Showing results (31-40 of 51) with videos related to

Pageof 6

Sort By:

Journal of Clinical Pharmacology|October 22, 2005

In vivo metabolic activity of CYP2C19 and CYP3A in relation to CYP2C19 genetic polymorphism in chronic liver diseaseAkihiro Ohnishi, Shigeto Murakami, Setsuko Akizuki, et al.

Journal of Pharmaceutical Health Care and Sciences|November 30, 2016

Influence of proton pump inhibitors and histamine H<sub>2</sub> receptor antagonists on serum phosphorus level control by calcium carbonate in patients undergoing hemodialysis: a retrospective medical chart reviewMasaomi Tatsuzawa, Ryuichi Ogawa, Atsushi Ohkubo, et al.

Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|March 31, 2004

[Effects of angiotensin II receptor blockers, angiotensin converting enzyme inhibitors, 3-hydroxy-3-methyl glutaryl (HMG) CoA reductase inhibitors, amlodipine and epalrestat on cultured basilar artery smooth muscle cell proliferation]Tomoaki Yamaguchi, Takashi Ida, Masazumi Hiraga, et al.

International Journal of Clinical Pharmacology and Therapeutics|February 4, 2017

Delayed de-induction of CYP2C9 compared to CYP3A after discontinuation of rifampicin: Report of two cases Soichi Shibata, Harumi Takahashi, Akiyasu Baba, et al.

Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 6, 2003

Reduced urinary 6beta-hydroxycortisol to cortisol ratios in patients with liver cirrhosisMasahiko Shibuya, Hirotoshi Echizen, Suzuko Kubo, et al.

Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|February 11, 2004

[Alterations of antiproliferative effects of serum obtained from patients with acute cerebral infarction treated with a radical scavenger, edaravone, with or without amlodipine using an in vitro cultured basilar artery smooth muscle cells]Tomoaki Yamaguchi, Takashi Ida, Takayoshi Kobayashi, et al.

Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|September 3, 2019

[A Retrospective Evaluation of the Impact of Multi-disciplinary Approach for Improving the Quality of Anticoagulation Therapy in Ambulatory Patients with Non-valvular Atrial Fibrillation Receiving Warfarin]Atsushi Ohgushi, Natsumi Nakayama, Atsuo Namiki, et al.

Journal of Pharmaceutical Health Care and Sciences|January 29, 2016

Risk of major bleeding at different PT-INR ranges in elderly Japanese patients with non-valvular atrial fibrillation receiving warfarin: a nested case-control studyAtsushi Ohgushi, Takayuki Ohtani, Natsumi Nakayama, et al.

Clinical Pharmacology and Therapeutics|August 22, 2002

Risk factors for antituberculous chemotherapy-induced hepatotoxicity in Japanese pediatric patientsKatsushito Ohkawa, Masayuki Hashiguchi, Keiko Ohno, et al.

Blood|April 9, 2004

5'-Flanking region polymorphisms of CYP2C9 and their relationship to S-warfarin metabolism in white and Japanese patientsHarumi Takahashi, Ichiro Ieiri, Grant R Wilkinson, et al.

Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:

Pageof 6

Journal of Clinical Pharmacology|October 22, 2005

In vivo metabolic activity of CYP2C19 and CYP3A in relation to CYP2C19 genetic polymorphism in chronic liver diseaseAkihiro Ohnishi, Shigeto Murakami, Setsuko Akizuki, et al.

Journal of Pharmaceutical Health Care and Sciences|November 30, 2016

Influence of proton pump inhibitors and histamine H<sub>2</sub> receptor antagonists on serum phosphorus level control by calcium carbonate in patients undergoing hemodialysis: a retrospective medical chart reviewMasaomi Tatsuzawa, Ryuichi Ogawa, Atsushi Ohkubo, et al.

Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|March 31, 2004

[Effects of angiotensin II receptor blockers, angiotensin converting enzyme inhibitors, 3-hydroxy-3-methyl glutaryl (HMG) CoA reductase inhibitors, amlodipine and epalrestat on cultured basilar artery smooth muscle cell proliferation]Tomoaki Yamaguchi, Takashi Ida, Masazumi Hiraga, et al.

International Journal of Clinical Pharmacology and Therapeutics|February 4, 2017

Delayed de-induction of CYP2C9 compared to CYP3A after discontinuation of rifampicin: Report of two cases Soichi Shibata, Harumi Takahashi, Akiyasu Baba, et al.

Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 6, 2003

Reduced urinary 6beta-hydroxycortisol to cortisol ratios in patients with liver cirrhosisMasahiko Shibuya, Hirotoshi Echizen, Suzuko Kubo, et al.

Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|February 11, 2004

[Alterations of antiproliferative effects of serum obtained from patients with acute cerebral infarction treated with a radical scavenger, edaravone, with or without amlodipine using an in vitro cultured basilar artery smooth muscle cells]Tomoaki Yamaguchi, Takashi Ida, Takayoshi Kobayashi, et al.

Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|September 3, 2019

[A Retrospective Evaluation of the Impact of Multi-disciplinary Approach for Improving the Quality of Anticoagulation Therapy in Ambulatory Patients with Non-valvular Atrial Fibrillation Receiving Warfarin]Atsushi Ohgushi, Natsumi Nakayama, Atsuo Namiki, et al.

Journal of Pharmaceutical Health Care and Sciences|January 29, 2016

Risk of major bleeding at different PT-INR ranges in elderly Japanese patients with non-valvular atrial fibrillation receiving warfarin: a nested case-control studyAtsushi Ohgushi, Takayuki Ohtani, Natsumi Nakayama, et al.

Clinical Pharmacology and Therapeutics|August 22, 2002

Risk factors for antituberculous chemotherapy-induced hepatotoxicity in Japanese pediatric patientsKatsushito Ohkawa, Masayuki Hashiguchi, Keiko Ohno, et al.

Blood|April 9, 2004

5'-Flanking region polymorphisms of CYP2C9 and their relationship to S-warfarin metabolism in white and Japanese patientsHarumi Takahashi, Ichiro Ieiri, Grant R Wilkinson, et al.

Pageof 6